Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
International standards for tuberculosis care
Part of the reason for failing to bring about a more rapid reduction in tuberculosis incidence
worldwide is the lack of effective involvement of all practitioners—public and private—in the …
worldwide is the lack of effective involvement of all practitioners—public and private—in the …
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration
Access to medicines and vaccines to prevent and treat non-communicable diseases (NCDs)
is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and …
is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and …
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes
Abstract Background. Type 2 diabetes (DM) is a strong risk factor for tuberculosis (TB) and is
associated with a slower response to TB treatment and a higher mortality rate. Because …
associated with a slower response to TB treatment and a higher mortality rate. Because …
Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA
SK Heysell, JL Moore, SJ Keller… - Emerging infectious …, 2010 - pmc.ncbi.nlm.nih.gov
Therapeutic drug monitoring may be useful in tuberculosis management, but programmatic
implementation is understudied. We performed a retrospective cohort study to determine …
implementation is understudied. We performed a retrospective cohort study to determine …
Nanotechnology in tuberculosis: state of the art and the challenges ahead
E Grotz, N Tateosian, N Amiano, M Cagel… - Pharmaceutical …, 2018 - Springer
Tuberculosis (TB) remains as the second most-deadly infection right behind the HIV/AIDS.
Actually, in 2016, TB incidence was estimated in 10.4 million cases. Although an efficient …
Actually, in 2016, TB incidence was estimated in 10.4 million cases. Although an efficient …
[ספר][B] Handbook of bioequivalence testing
SK Niazi - 2007 - taylorfrancis.com
As the generic pharmaceutical industry continues to grow and thrive, so does the need to
conduct efficient and successful bioequivalence studies. In recent years, there have been …
conduct efficient and successful bioequivalence studies. In recent years, there have been …
Gelatin nanoparticles as carrier for effective antituberculosis drug delivery in combination therapy
Gelatin nanoparticles, synthesized via desolvation, serve as effective carriers for anti-
tuberculosis drugs in both single and combination therapies. Characterization through …
tuberculosis drugs in both single and combination therapies. Characterization through …
Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents: miniperspectives series on phenotypic screening for …
CB Cooper - Journal of Medicinal Chemistry, 2013 - ACS Publications
The global pandemic of drug sensitive tuberculosis (TB) as well as the increasing threat from
various multidrug resistant forms of TB drives the quest for newer, safer, more effective TB …
various multidrug resistant forms of TB drives the quest for newer, safer, more effective TB …
Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier
Studies related to loading ability and delivery of clinically used first-line anti-tuberculosis
drugs (ATDs) such as isoniazid, rifampicin, pyrazinamide and streptomycin on the surface of …
drugs (ATDs) such as isoniazid, rifampicin, pyrazinamide and streptomycin on the surface of …
Application of nanotechnology for cancer treatment
Cancer has become a big threat to mankind worldwide. This disease is the second most
common disease with maximum mortality. According to the recent report from ICMR, 1300 …
common disease with maximum mortality. According to the recent report from ICMR, 1300 …